BLACKMORES LIMITED (BKL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BKL - BLACKMORES LIMITED

FNArena Sector : Health & Nutrition
Year End: June
GICS Industry Group : Household & Personal Products
Index: ASX200 | ASX300 | ALL-ORDS

Blackmores is Australia's leading natural health supplement company manufacturing and marketing a range of food supplements, including vitamins, mineral and herb products. Founded in 1932, it became a public company in 1985.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$71.63

22 Jan
2021

0.090

OPEN

$71.00

0.13%

HIGH

$71.94

15,150

LOW

$71.00

TARGET
$66.958 -6.5% downside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . MCP . API . EXL . SIG . CLV .
MARKET CONSENSUS FORECAST
BKL: 1
Title FY19
Actual		 FY20
Actual		 FY21
Forecast		 FY22
Forecast
EPS (cps) xxx 103.5 182.0 xxx
DPS (cps) xxx 0.0 122.8 xxx
EPS Growth xxx - 66.5% 75.8% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 39.4 xxx
Dividend Yield xxx N/A 1.7% xxx
Div Pay Ratio(%) xxx 0.0% 67.5% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 27/08 - 70c (100%)

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

-0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

xx/xx/xxxx

3

xxxxxxx xx xxxxxxx xxxx xxxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

26/08/2020

3

Equal-weight

$67.00

-6.46%

Underlying net profit in FY20 was in line with guidance. Profit growth is expected to resume in the second half of FY21. Morgan Stanley notes Blackmores will reduce personnel by -10%.

This is deemed necessary because growth in employee numbers has not been accompanied by commensurate revenue growth.

The broker notes plenty of longer-term margin potential amid cost reductions, with the reduction in personnel a start. Morgan Stanley retains an Equal-weight rating. Target is $67. Industry view is Cautious.

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >

BKL STOCK CHART

FNArena News on BKL

1
Australian Broker Call *Extra* Edition – Nov 18, 2020

Nov 18 2020 - Daily Market Reports
2
Thirteen Value Stocks That Could Surge On Rotation

Nov 17 2020 - FYI
3
Australian Broker Call *Extra* Edition – Nov 09, 2020

Nov 09 2020 - Daily Market Reports
4
McPherson’s Expands Into Herbal Health

Nov 04 2020 - Small Caps
5
Weekly Ratings, Targets, Forecast Changes – 30-10-20

Nov 02 2020 - Weekly Reports

Latest Health & Nutrition News

1
McPherson’s Expands Into Herbal Health

Nov 04 2020 - Small Caps
2
Nine Ignored Companies Now Worth A Look

Sep 23 2020 - FYI
3
Next Week At A Glance – 14-18 Sep 2020

Sep 11 2020 - Weekly Reports
4
Sigma Farewells API, Heralds New Contract

Dec 17 2019 - Australia
5
Blackmores: Hopes Pinned On Restructuring

Nov 01 2019 - Australia
6
Blackmores Peps Up Its Strategy For China

Apr 17 2019 - Australia
7
API/Sigma Merger Plan Rears, Again

Dec 17 2018 - Australia
8
Uncertainty Hinders Sigma Pharmaceuticals

Sep 11 2018 - Small Caps
9
Goodbye Chemist Warehouse, Hello Capital Return?

Jul 03 2018 - Australia
10
Healthier Growth Required From Blackmores

Apr 27 2018 - Australia